HMGN (Hemagen Diagnostics) Total Current Liabilities: $1.95 Mil (As of Sep. 2012)


What is Hemagen Diagnostics Total Current Liabilities?

Hemagen Diagnostics HMGN +766.67% Total Current Liabilities is $1.95 Mil as of Sep. 2012.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Hemagen Diagnostics's total current liabilities for the quarter that ended in Sep. 2012 was $1.95

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Hemagen Diagnostics Total Current Liabilities Related Terms

Hemagen Diagnostics Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Hemagen Diagnostics's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemagen Diagnostics Total Current Liabilities Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.74 1.45 1.17 1.53 1.95

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.53 1.58 1.79 1.91 1.95

Hemagen Diagnostics Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Hemagen Diagnostics's Total Current Liabilities for the fiscal year that ended in Sep. 2012 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.952+0.977
+Other Current Liabilities+Current Deferred Liabilities
=2.2204460492503E-16+0.021
=1.95

Hemagen Diagnostics's Total Current Liabilities for the quarter that ended in Sep. 2012 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.952+0.977
+Other Current Liabilities+Current Deferred Liabilities
=2.2204460492503E-16+0.021
=1.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of $1.95 Mil mean?
Hemagen Diagnostics (HMGN) has a Total Current Liabilities of $1.95 Mil as of Sep. 2012. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Hemagen Diagnostics and its competitors.
Is Hemagen Diagnostics' Total Current Liabilities too high?
Hemagen Diagnostics' current Total Current Liabilities is $1.95 Mil.
How does Hemagen Diagnostics' Total Current Liabilities compare to OBMP and NSPX?
Hemagen Diagnostics' Total Current Liabilities of $1.95 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Biotechnology company?
A good Total Current Liabilities depends on the Biotechnology industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Hemagen Diagnostics and its competitors. Hemagen Diagnostics's current Total Current Liabilities is $1.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemagen Diagnostics stock overvalued right now?
Hemagen Diagnostics (HMGN) has a current Total Current Liabilities of $1.95 Mil. The current Total Current Liabilities is $1.95 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Hemagen Diagnostics (HMGN), the current Total Current Liabilities is $1.95 Mil as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemagen Diagnostics Business Description

Address 9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.